JP2025515036A5 - - Google Patents
Info
- Publication number
- JP2025515036A5 JP2025515036A5 JP2024564691A JP2024564691A JP2025515036A5 JP 2025515036 A5 JP2025515036 A5 JP 2025515036A5 JP 2024564691 A JP2024564691 A JP 2024564691A JP 2024564691 A JP2024564691 A JP 2024564691A JP 2025515036 A5 JP2025515036 A5 JP 2025515036A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- pharmaceutically acceptable
- acceptable salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263363962P | 2022-05-02 | 2022-05-02 | |
| US63/363,962 | 2022-05-02 | ||
| PCT/US2023/019770 WO2023215133A1 (en) | 2022-05-02 | 2023-04-25 | Pikfyve kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515036A JP2025515036A (ja) | 2025-05-13 |
| JP2025515036A5 true JP2025515036A5 (https=) | 2026-04-28 |
Family
ID=86604380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564691A Pending JP2025515036A (ja) | 2022-05-02 | 2023-04-25 | ＰＩＫｆｙｖｅキナーゼ阻害剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250282767A1 (https=) |
| EP (1) | EP4519255A1 (https=) |
| JP (1) | JP2025515036A (https=) |
| WO (1) | WO2023215133A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL309445A (en) | 2021-06-22 | 2024-02-01 | Acurastem Inc | PIKFYVE antisense oligonucleotides |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6693097B2 (en) | 2001-11-30 | 2004-02-17 | Synta Pharmaceuticals Corp. | Pyrimidine compounds |
| WO2006128129A2 (en) | 2005-05-26 | 2006-11-30 | Synta Pharmaceuticals Corp. | Method for treating cancer |
| KR20110017445A (ko) * | 2008-06-11 | 2011-02-21 | 아스트라제네카 아베 | 암 및 골수증식성 장애의 치료에 유용한 트리시클릭 2,4-디아미노-ｌ,3,5-트리아진 유도체 |
| US10758545B2 (en) | 2015-06-25 | 2020-09-01 | University Of Southern California | Methods to treat neurological diseases |
| CA3050021A1 (en) * | 2017-01-25 | 2018-08-02 | Glaxosmithkline Intellectual Property Development Limited | Compounds |
| JP2020505399A (ja) * | 2017-01-25 | 2020-02-20 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | 化合物 |
| WO2019046316A1 (en) | 2017-08-28 | 2019-03-07 | Acurastem Inc. | PIKFYVE KINASE INHIBITORS |
| JP7290651B2 (ja) * | 2018-02-07 | 2023-06-13 | ウーシー・バイオシティ・バイオファーマシューティクス・カンパニー・リミテッド | Ａｔｒ阻害剤及びその応用 |
| CN118619944A (zh) * | 2019-06-06 | 2024-09-10 | 北京泰德制药股份有限公司 | 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物 |
| WO2021163727A1 (en) | 2020-02-11 | 2021-08-19 | AcuraStem Incorporated | Pikfyve kinase inhibitors |
-
2023
- 2023-04-25 JP JP2024564691A patent/JP2025515036A/ja active Pending
- 2023-04-25 EP EP23726667.1A patent/EP4519255A1/en active Pending
- 2023-04-25 WO PCT/US2023/019770 patent/WO2023215133A1/en not_active Ceased
- 2023-04-25 US US18/862,354 patent/US20250282767A1/en active Pending